4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001725663-26-000003
Chief Financial Officer sold 16,477 shares at an average $13.01 ($214,379)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
WENTWORTH KORY JAMES · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-09 | Sale : show line 1 in the form 10b5-1 | −5,089 | $13.00 | $66,163 | 132,898 | D |
| 2026-03-10 | Sale : show line 2 in the form 10b5-1 | −11,388 | $13.02 | $148,216 | 121,510 | D |
| Open-market sales · 16,477 sh · avg $13.01 · $214,379 | ||||||
Loading xslF345X05/wk-form4_1773261246.xml…